SNT (Suc1-binding Neurotrophic factor-induced Tyrosine-phosphorylated target) proteins are recently discovered adaptor molecules that undergo rapid tyrosine phosphorylation following stimulation by growth factors including neurotrophins (NGF, BDNF, NT3) and FGFs but not by insulin and EGF. They are distantly related to IRS. SNTs are myristoylated and membrane-anchored and bear an N-terminal phosphotyrosine-binding (PTB) domain that mediates weak, but functionally significant SNT-receptor interactions. The ligand- dependent tyrosine phosphorylation of SNTs enables SNTs to interact with at least two different SH2 domain-containing moieties, Grb2/Sos and Shp2. As activation of both the Grb2/Sos and the subsequent Ras activation as well as the Shp2 phosphatase has been shown to be required for a wide-range of FGF- and neurotrophin- induced biological responses, SNTs may be required for activation of two biologically critical pathways.
Three aims are proposed in this application to elucidate the biochemical and biological properties of SNTs.
Aim 1 is proposed to determine the nature of the interaction between SNT PTB domains by using a combination of NMR and mutagenesis approaches. A possible direct interaction between SNTs and another receptor tyrosine kinase Ret will also be tested.
In specific aim 2, the biological function of SNT1 and SNT2 will be addressed. Two approaches will be undertaken for this purpose: 1.) Dominant negative mutants of SNTs will be overexpressed in cultured cells and 2.) Mice with null, hypmerorphs and conditional null mutations in SNT genes will be generated. Finally, in specific aim 3, the idea of SNTs serving as potential biological specificity determinants will be tested. To this end, chimeric SNT-IRS as well as insulin receptor-Trk hybrids will be produced to determine if they can turn insulin response to that of neurotrophins or FGFs.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM059432-04
Application #
6520039
Study Section
Special Emphasis Panel (ZRG1-MDCN-2 (01))
Program Officer
Cole, Alison E
Project Start
1999-05-01
Project End
2004-04-30
Budget Start
2002-05-01
Budget End
2004-04-30
Support Year
4
Fiscal Year
2002
Total Cost
$371,520
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Biology
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Schoorlemmer, J; Goldfarb, M (2001) Fibroblast growth factor homologous factors are intracellular signaling proteins. Curr Biol 11:793-7
Hama, J; Xu, H; Goldfarb, M et al. (2001) SNT-1/FRS2alpha physically interacts with Laloo and mediates mesoderm induction by fibroblast growth factor. Mech Dev 109:195-204
Dhalluin, C; Yan, K S; Plotnikova, O et al. (2000) 1H, 13C and 15N resonance assignments of the SNT PTB domain in complex with FGFR1 peptide. J Biomol NMR 18:371-2